Close Menu

Technical University Munich

The agreement is to support the company’s analytical and preanalytical research and assist in its trials aimed at a number of cancers.  

RNA sequencing of patient-derived fibroblasts was able to provide 10 percent of patients with a diagnosis after whole-exome sequencing had failed.